Replay | Healthcare Speaker Call: COVID-19 Impacts Hedgeye Subscribers: CLICK HERE for audio replay |
Details | If you weren't able to catch us live, please enjoy the replay of a very interesting conference call with Dennis Grimaud, the Co-Founder and former CEO of DIATHERIX Laboratories. DIATHERIX, which has been acquired by Eurofins, is a leader in the development of diagnostic tools to aid in the identification and treatment of viral disease including H1N1 and a host of coronavirus.
Dennis, Tom Tobin, and I discussed those topics which have been top of mind as investors try and assess the impact of COVID-19 testing, diagnosis and treatment, including:
- What may have gone wrong in China and how that impacted mortality rates
- Mis-steps by US in containment and the implications for the spread of disease
- At-risk populations and complications that may give rise to hospitalizations or not.
- Rate if Change in Testing v Rate of Change in Disease Spread
- Regional hotspots or national impact
Please call if you have any follow- up questions.
Emily Evans
Managing Director – Health Policy
Twitter
LinkedIn